Rosen Law Firm Investigates TruBridge Securities Claims
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 02 2026
0mins
Source: PRnewswire
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ:TBRG) due to allegations of misleading business information, which may undermine investor confidence following the delayed filing of its 2025 fiscal year annual report.
- Financial Reporting Errors: On March 17, 2026, TruBridge acknowledged errors in its financial statements, including those for 2024 and 2023, necessitating revisions that could impact the company's future financial transparency and investor trust.
- Stock Price Decline: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns over the company's financial health and investor panic.
- Class Action Preparation: Rosen Law Firm is preparing a class action lawsuit, allowing investors to seek compensation without any out-of-pocket costs, which may attract more affected investors and further intensify TruBridge's legal and financial pressures.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TBRG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TBRG
Wall Street analysts forecast TBRG stock price to fall
2 Analyst Rating
0 Buy
2 Hold
0 Sell
Hold
Current: 26.070
Low
21.00
Averages
22.00
High
23.00
Current: 26.070
Low
21.00
Averages
22.00
High
23.00
About TBRG
TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ:TBRG) due to allegations of materially misleading business information, indicating serious issues in the company's financial reporting that could undermine investor confidence.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, stating its inability to file its Annual Report for the fiscal year ended December 31, 2025, due to the identification of errors in previously issued financial statements, raising concerns about the company's financial transparency.
- Stock Price Decline Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns over the company's financial health and potentially impacting its future financing capabilities.
- Class Action Preparation: Rosen Law Firm is preparing a class action to seek recovery of investor losses, indicating that the legal risks faced by the company may exacerbate its financial pressures while also potentially affecting its reputation and market position.
See More
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) due to allegations of issuing materially misleading business information, indicating significant legal risks that could undermine investor confidence.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, revealing its inability to submit its Annual Report for the fiscal year 2025 due to identified errors in previously issued financial statements, raising concerns about the company's financial transparency.
- Stock Price Decline: Following the announcement of the delayed financial report, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market apprehension regarding the company's financial health and potential investor losses.
- Class Action Preparation: The Rosen Law Firm is preparing a class action lawsuit against TruBridge, allowing investors to seek compensation without any out-of-pocket costs, indicating that the company may face increased legal liabilities and financial pressures.
See More
- Securities Claims Investigation: The Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) due to allegations of misleading business information, indicating significant risks in the company's information disclosure practices.
- Delayed Financial Reporting: TruBridge's Form 12b-25 filed on March 17, 2026, reveals the company failed to file its Annual Report for the fiscal year 2025 due to identified errors in prior financial statements, which may undermine investor confidence in the company's financial health.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and management capabilities.
- Class Action Preparation: The Rosen Law Firm is preparing a class action lawsuit, allowing investors to seek compensation without any out-of-pocket costs, suggesting that the legal risks faced by the company could significantly impact its future financial performance.
See More
- Targeted Companies: Halper Sadeh LLC is investigating Avanos Medical, Inc., Nuvalent, Inc., XOMA Royalty Corporation, and TruBridge, Inc. for potential violations of federal securities laws or breaches of fiduciary duties, including Avanos's sale to American Industrial Partners for $25.00 per share.
- Shareholder Rights: Shareholders are encouraged to contact Halper Sadeh LLC to discuss their rights and options, with the firm offering to handle matters on a contingent fee basis, emphasizing its commitment to protecting shareholder interests.
- Potential Benefits: The investigation may lead to increased consideration or additional disclosures for shareholders, indicating Halper Sadeh LLC's dedication to securing better financial outcomes and transparency for investors.
- Legal Advocacy: Halper Sadeh LLC represents investors globally, focusing on securities fraud and corporate misconduct cases, having successfully recovered millions for defrauded investors, showcasing its expertise in safeguarding investor rights.
See More
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) due to allegations of issuing materially misleading business information, indicating possible investor losses and damaging the company's market reputation.
- Delayed Financial Reporting: TruBridge's Notification of Late Filing on Form 12b-25, submitted on March 17, 2026, reveals the company failed to file its Annual Report for the fiscal year ended December 31, 2025, due to identified errors in previously issued financial statements, which may undermine investor confidence in its financial transparency.
- Stock Price Decline: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial health and operational integrity.
- Class Action Preparation: Rosen Law Firm is preparing a class action to seek compensation for affected investors, indicating that the company may face significant legal and financial risks moving forward.
See More

- Investigation Focus: Halper Sadeh LLC is investigating Caesars Entertainment, Inc. (NASDAQ:CZR) for potential violations of federal securities laws related to its sale to Fertitta Entertainment, Inc. for $31.00 per share, which may impact shareholder rights.
- RE/MAX Transaction: RE/MAX Holdings, Inc. (NYSE:RMAX) is set to sell to The Real Brokerage Inc. for either 5.152 shares of the combined company or $13.80 in cash per share, potentially limiting superior competing offers and affecting shareholder options.
- TruBridge Sale: TruBridge, Inc. (NASDAQ:TBRG) plans to sell to Inventurus Knowledge Solutions, Inc. for $26.25 in cash per share, with Halper Sadeh LLC possibly seeking increased consideration and additional disclosures on behalf of shareholders.
- Sila Realty Deal: Sila Realty Trust, Inc. (NYSE:SILA) intends to sell to affiliates of Blue Owl Real Estate Capital LLC for $30.38 per share, and Halper Sadeh LLC will represent shareholders in seeking legal rights and remedies.
See More






